BAXTER INTERNATIONAL INC.;CBR INSTITUTE FOR BIOMEDICAL RESEARCH;BAXTER HEALTHCARE S.A.
发明人:
WAGNER, DENISA,CHAUHAN, ANIL KUMAR,SCHEIFLINGER, FRIEDRICH,PLAIMAUER, BARBARA
申请号：
CA2606351
公开号：
CA2606351C
申请日:
2006.06.16
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
This invention relates to a pharmaceutical composition having thrombolyticactivity comprising ADAMTS13, and to methods for treating or preventing adisorder associated with the formation and/or the presence of one or morethrombus and to methods of disintegrating one or more thrombus in a patient inneed thereof. Furthermore, the invention relates to the use of apharmaceutically effective amount of ADAMTS13 for the preparation of apharmaceutical composition for treating or preventing a disorder associatedwith the formation or the presence of one or more thrombus and fordisintegrating one or more thrombus in a patient in need thereof.
